JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
CALL
Prudential Financial
PRU
$39.3B
| $15.9M | ﹤0.01% |
134,400
-116,700
| -46% | -$14.4M |
2021 Q1
15 quarters
|
|
2202
Mirum Pharmaceuticals
MIRM
$5.31B
| $15.9M | ﹤0.01% |
385,142
+357,381
| +1,287% | +$14.9M |
2019 Q3
21 quarters
|
|
|
FBMS
2203
DELISTED
The First Bancshares, Inc.
FBMS
| $15.9M | ﹤0.01% |
455,002
-20,012
| -4% | -$697K |
2017 Q4
28 quarters
|
|
2204
CALL
Wynn Resorts
WYNN
$7.94B
| $15.9M | ﹤0.01% |
184,600
-2,700
| -1% | -$255K |
2023 Q4
4 quarters
|
|
2205
Arcutis Biotherapeutics
ARQT
$3.18B
| $15.9M | ﹤0.01% |
1,141,505
-155,406
| -12% | -$1.7M |
2020 Q1
19 quarters
|
|
|
ITOS
2206
DELISTED
iTeos Therapeutics
ITOS
| $15.9M | ﹤0.01% |
2,068,796
+1,601,477
| +343% | +$13.8M |
2020 Q3
17 quarters
|
|
2207
iShares Global Infrastructure ETF
IGF
$10.2B
| $15.9M | ﹤0.01% |
303,665
-206,694
| -40% | -$11.2M |
2013 Q2
46 quarters
|
|
2208
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.72B
| $15.8M | ﹤0.01% |
168,990
-669,470
| -80% | -$63.3M |
2023 Q3
5 quarters
|
|
2209
CALL
Linde
LIN
$223B
| $15.8M | ﹤0.01% |
37,800
+20,500
| +118% | +$9.34M |
2023 Q2
6 quarters
|
|
2210
First Busey Corp
BUSE
$2.45B
| $15.8M | ﹤0.01% |
671,402
+189,115
| +39% | +$4.84M |
2013 Q2
46 quarters
|
|
2211
PUT
Newmont
NEM
$123B
| $15.8M | ﹤0.01% |
425,000
+100,000
| +31% | +$4.56M |
2024 Q3
1 quarter
|
|
2212
Cathay General Bancorp
CATY
$4.06B
| $15.8M | ﹤0.01% |
331,862
+175,737
| +113% | +$8.47M |
2013 Q2
46 quarters
|
|
2213
Minerals Technologies
MTX
$2.07B
| $15.8M | ﹤0.01% |
207,033
+91,146
| +79% | +$7.18M |
2013 Q2
46 quarters
|
|
|
TLN
2214
Talen Energy Corp
TLN
$15.9B
| $15.7M | ﹤0.01% |
77,956
-53,787
| -41% | -$10.5M |
2024 Q3
1 quarter
|
|
2215
PUT
Marriott International
MAR
$92.9B
| $15.7M | ﹤0.01% |
56,300
+5,000
| +10% | +$1.37M |
2024 Q3
1 quarter
|
|
2216
First Commonwealth Financial
FCF
$2.07B
| $15.7M | ﹤0.01% |
927,453
+295,011
| +47% | +$5.21M |
2013 Q2
46 quarters
|
|
2217
Victory Capital Holdings
VCTR
$7.12B
| $15.7M | ﹤0.01% |
239,333
-133,599
| -36% | -$8.46M |
2020 Q1
19 quarters
|
|
2218
Dimensional International Core Equity 2 ETF
DFIC
$15.1B
| $15.7M | ﹤0.01% |
605,877
+26,592
| +5% | +$713K |
2022 Q4
8 quarters
|
|
|
LNW
2219
DELISTED
Light & Wonder
LNW
| $15.6M | ﹤0.01% |
181,067
-102,892
| -36% | -$9.64M |
2013 Q2
46 quarters
|
|
2220
Liberty Live Group Series A
LLYVA
$8.88B
| $15.6M | ﹤0.01% |
234,643
-109,605
| -32% | -$6.8M |
2023 Q3
5 quarters
|
|
|
ALEX
2221
DELISTED
Alexander & Baldwin
ALEX
| $15.6M | ﹤0.01% |
880,018
+297,044
| +51% | +$5.6M |
2013 Q2
46 quarters
|
|
2222
WisdomTree US MidCap Dividend Fund
DON
$3.82B
| $15.6M | ﹤0.01% |
306,136
-22,071
| -7% | -$1.16M |
2013 Q2
46 quarters
|
|
2223
Xperi
XPER
$264M
| $15.6M | ﹤0.01% |
1,519,100
+666,226
| +78% | +$6.22M |
2022 Q4
8 quarters
|
|
2224
Independent Bank Corp
IBCP
$799M
| $15.6M | ﹤0.01% |
447,690
+59,339
| +15% | +$2.11M |
2015 Q3
37 quarters
|
|
2225
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.77B
| $15.5M | ﹤0.01% |
147,357
+7,620
| +5% | +$828K |
2018 Q4
24 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.